SEDAR Filings

Effective August 1, 2016, Zenith Epigenetics became a wholly owned subsidiary of Zenith Capital Corp.  

Zenith Capital Corp., a biotechnology investment company, is a reporting issuer in all Provinces of Canada. 

The following documents require Adobe Acrobat Reader, click to download.


2022 2021 2020 2019 2018 2017 2016 2015